ELIFE Holdings (00223) receives resumption guidance from the Stock Exchange.

ELIFE HLDGS (00223) issued an announcement on January 15, 2025, regarding the resumption of trading in its shares by the Stock Exchange. The announcement included the following resumption guidance: (a) Publish all outstanding financial results in accordance with listing rules and address any audit modifications; (b) Conduct an independent forensic investigation into certain operating subsidiaries of the company for the first half of 2024, evaluate the impact on the company's business operations and financial condition, disclose the investigation results, and take appropriate remedial actions; (c) Demonstrate that there are no reasonable doubts about the integrity, ability, and/or character of individuals with significant influence over the group's management and/or company management and operations that may pose risks to investors and market confidence; (d) Conduct an independent internal monitoring review and demonstrate that the company has sufficient internal monitoring and procedures to comply with listing rules; (e) Demonstrate compliance with Listing Rule 13.24; (f) Disclose all material information to the market for shareholders and other investors to evaluate the company's status.